Xenon Pharmaceuticals (XENE) Other Working Capital Changes (2020 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Other Working Capital Changes of -$349000.0 for Q1 2026, down 13.68% year-over-year from -$404313.2 in Q1 2025, and down 4.18% quarter-over-quarter from -$335000.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Other Working Capital Changes for 6 consecutive years, with -$349000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 13.68% year-over-year to -$349000.0; the TTM figure through Mar 2026 stood at -$1.3 million (down 8.77% YoY), while the FY2025 annual figure was -$1.3 million, down 6.31% from the prior year.
- Other Working Capital Changes slipped to -$349000.0 in Q1 2026 per XENE's latest filing, from -$335000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $6.5 million in Q4 2022 and bottomed at -$6.6 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged $855529.4 across 5 years, with a median of $673000.0 in 2024.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes surged 72.75% — and 2026, when it retreated 13.68%.
- Xenon Pharmaceuticals' Other Working Capital Changes stood at -$600000.0 in 2022, then surged by 47.0% to -$318000.0 in 2024, then retreated by 5.35% to -$335000.0 in 2025, then declined by 4.18% to -$349000.0 in 2026.
- Business Quant data shows XENE's Other Working Capital Changes at -$349000.0 in Q1 2026, -$335000.0 in Q4 2025, and -$337000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -358,000.00 |
| Jun 30, 2026 | -358,000.00 |
| Jun 30, 2026 | -358,000.00 |
| Mar 31, 2026 | -349,000.00 |
| Mar 31, 2026 | -349,000.00 |
| Mar 31, 2026 | -349,000.00 |
| Dec 31, 2025 | -335,000.00 |
| Dec 31, 2025 | -335,000.00 |
| Dec 31, 2025 | -335,000.00 |
| Sep 30, 2025 | -337,000.00 |
| Sep 30, 2025 | -337,000.00 |
| Sep 30, 2025 | -337,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Dec 31, 2024 | -318,000.00 |
| Dec 31, 2024 | -318,000.00 |